sgRNAs: A SARS-CoV-2 emerging issue
- PMID: 37519862
- PMCID: PMC10105645
- DOI: 10.1016/j.amolm.2023.100008
sgRNAs: A SARS-CoV-2 emerging issue
Abstract
Like for other coronaviruses, SARS-CoV-2 gene expression strategy is based on the synthesis of a nested set of subgenomic mRNA species (sgRNAs). These sgRNA are synthesized using a "discontinuous transcription" mechanism that relies on template switching at Transcription Regulatory Sequences (TRS). Both canonical (c-sgRNA) and non-canonical (nc-sgRNA, less numerous) subgenomic RNA species can be produced. Currently, sgRNAs are investigated on the basis of sequence data obtained through next generation sequencing (NGS), and bioinformatic tools are crucial for their identification, characterization and quantification. To date, few software have been developed to this aim, whose reliability and applicability to all the available NGS platforms need to be established, to build confidence on the information resulting from such tools. In fact, these information may be crucial for the in depth elucidation of viral expression strategy, particularly in respect of the significance of nc-sgRNAs, and for the possible use of sgRNAs as potential markers of virus replicative activity in infected patients.
Keywords: Bioinformatics; Coronavirus; Next-generation sequencing; SARS-CoV2; Viruses; sgRNAs.
© 2023 The Authors.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

Similar articles
-
Comparative analysis of bioinformatics tools to characterize SARS-CoV-2 subgenomic RNAs.Life Sci Alliance. 2023 Sep 25;6(12):e202302017. doi: 10.26508/lsa.202302017. Print 2023 Dec. Life Sci Alliance. 2023. PMID: 37748810 Free PMC article.
-
Pervasive generation of non-canonical subgenomic RNAs by SARS-CoV-2.Genome Med. 2020 Dec 1;12(1):108. doi: 10.1186/s13073-020-00802-w. Genome Med. 2020. PMID: 33256807 Free PMC article.
-
Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens.Microbiol Spectr. 2022 Apr 27;10(2):e0018222. doi: 10.1128/spectrum.00182-22. Epub 2022 Mar 21. Microbiol Spectr. 2022. PMID: 35311586 Free PMC article.
-
SARS-CoV-2: from its discovery to genome structure, transcription, and replication.Cell Biosci. 2021 Jul 19;11(1):136. doi: 10.1186/s13578-021-00643-z. Cell Biosci. 2021. PMID: 34281608 Free PMC article. Review.
-
SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives.Viruses. 2021 Sep 24;13(10):1923. doi: 10.3390/v13101923. Viruses. 2021. PMID: 34696353 Free PMC article. Review.
Cited by
-
Performance of Subgenomic RT-PCR for Predicting SARS-CoV-2 Infectivity Compared to Genomic RT-PCR and Culture Isolation.J Med Virol. 2025 May;97(5):e70363. doi: 10.1002/jmv.70363. J Med Virol. 2025. PMID: 40272020 Free PMC article.
-
Deletion of 82-85 N-Terminal Residues in SARS-CoV-2 Nsp1 Restricts Virus Replication.Viruses. 2024 Apr 26;16(5):689. doi: 10.3390/v16050689. Viruses. 2024. PMID: 38793572 Free PMC article.
-
Improved sub-genomic RNA prediction with the ARTIC protocol.Nucleic Acids Res. 2024 Sep 23;52(17):e82. doi: 10.1093/nar/gkae687. Nucleic Acids Res. 2024. PMID: 39149898 Free PMC article.
-
Engineering a live-attenuated porcine reproductive and respiratory syndrome virus vaccine to prevent RNA recombination by rewiring transcriptional regulatory sequences.mBio. 2025 Feb 5;16(2):e0235024. doi: 10.1128/mbio.02350-24. Epub 2024 Dec 23. mBio. 2025. PMID: 39714179 Free PMC article.
References
-
- Bouhaddou M., Memon D., Meyer B., White K.M., Rezelj V.V., Correa Marrero M., Polacco B.J., Melnyk J.E., Ulferts S., Kaake R.M., Batra J., Richards A.L., Stevenson E., Gordon D.E., Rojc A., Obernier K., Fabius J.M., Soucheray M., Miorin L., Moreno E., Koh C., Tran Q.D., Hardy A., Robinot R., Vallet T., Nilsson-Payant B.E., Hernandez-Armenta C., Dunham A., Weigang S., Knerr J., Modak M., Quintero D., Zhou Y., Dugourd A., Valdeolivas A., Patil T., Li Q., Hüttenhain R., Cakir M., Muralidharan M., Kim M., Jang G., Tutuncuoglu B., Hiatt J., Guo J.Z., Xu J., Bouhaddou S., Mathy C.J.P., Gaulton A., Manners E.J., Félix E., Shi Y., Goff M., Lim J.K., McBride T., O'Neal M.C., Cai Y., Chang J.C.J., Broadhurst D.J., Klippsten S., De wit E., Leach A.R., Kortemme T., Shoichet B., Ott M., Saez-Rodriguez J., tenOever B.R., Mullins R.D., Fischer E.R., Kochs G., Grosse R., García-Sastre A., Vignuzzi M., Johnson J.R., Shokat K.M., Swaney D.L., Beltrao P., Krogan N.J. The global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182:685–712.e19. doi: 10.1016/J.CELL.2020.06.034/ATTACHMENT/2523A3EE-6406-4D91-B592-8E7E65AB0F71/MMC8.XLSX. - DOI - PMC - PubMed
-
- Chang J.J.Y., Rawlinson D., Pitt M.E., Taiaroa G., Gleeson J., Zhou C., Mordant F.L., De Paoli-Iseppi R., Caly L., Purcell D.F.J., Stinear T.P., Londrigan S.L., Clark M.B., Williamson D.A., Subbarao K., Coin L.J.M. Transcriptional and epi-transcriptional dynamics of SARS-CoV-2 during cellular infection. Cell Rep. 2021;35 doi: 10.1016/J.CELREP.2021.109108. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous